|
|
 |
|
Viewing report
|
|
|
|
Albany Molecular Research, Inc. - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011, Pages: 63
Albany Molecular Research, Inc. – Product Pipeline Review – H2 2011
Summary
Global Market Direct’s pharmaceuticals report, “Albany Molecular Research, Inc. - Product Pipeline Review - H2 2011” provides data on the Albany Molecular Research, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Albany Molecular Research, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Albany Molecular Research, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Albany Molecular Research, Inc. - Brief Albany Molecular Research, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Albany Molecular Research, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Albany Molecular Research, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Albany Molecular Research, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Albany Molecular Research, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Albany Molecular Research, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Albany Molecular Research, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Albany Molecular Research, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Albany Molecular Research, Inc. and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of Albany Molecular Research, Inc.; Albany Molecular Research, Inc. - Key Therapeutics; Albany Molecular Research, Inc. - Pipeline Overview and Promising Molecules; Albany Molecular Research, Inc. - News; Albany Molecular Research, Inc. - Latest Updates; Albany Molecular Research, Inc. - Pipeline; Albany Molecular Research, Inc. - Discontinued/Dormant Projects
|
|
|
|
